All Stories

  1. Durvalumab Consolidation Treatment after Chemoradiotherapy for an HIV-Positive Patient with Locally Advanced Non-Small Cell Lung Cancer
  2. Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer
  3. Ceritinib for an anaplastic lymphoma kinase rearrangement-positive patient previously treated with alectinib with poor performance status
  4. A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report
  5. Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1
  6. Cellulitis-like symptoms manifested by bone metastasis of lung cancer in a patient living with human immunodeficiency virus
  7. Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment
  8. Alectinib for choroidal metastasis in a patient with crizotinib-resistant ALK rearranged positive non-small cell lung cancer
  9. Response to Cytotoxic Chemotherapy in Patients Previously Treated With Palliative-Intent Chemotherapy for Advanced Thymic Carcinoma
  10. Lung cancer patients harboring epidermal growth factor receptor mutation among those infected by human immunodeficiency virus
  11. Clinical outcome of thymic lymphoepithelioma‑like carcinoma: Case report of a 14‑year‑old male
  12. Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy
  13. Crucial role of treatment with palliative intent for a patient with advanced thymic carcinoma
  14. Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center
  15. The potency of curative-intent treatment for advanced thymic carcinoma
  16. Clinical outcomes with chemotherapy for advanced thymic carcinoma
  17. Eligibility for Bevacizumab as an Independent Prognostic Factor for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study
  18. Concomitant Chemoradiotherapy and Antiretroviral Therapy for HIV-Infected Patients with Locoregionally Advanced Non-Small Cell Lung Cancer: Benefit and Tolerability of Treatment in 2 Cases
  19. Erratum to: A case of successful preoperative chemotherapy with cisplatin and irinotecan followed by curative-intent surgery for locally advanced thymic carcinoma
  20. A case of successful preoperative chemotherapy with cisplatin and irinotecan followed by curative-intent surgery for locally advanced thymic carcinoma
  21. Asymptomatic iris metastasis of small-cell lung cancer
  22. Cisplatin and irinotecan combination chemotherapy for advanced thymic carcinoma: Evaluation of efficacy and toxicity
  23. HIV and Lung Cancer
  24. Clinical characteristics of Japanese lung cancer patients with human immunodeficiency virus infection
  25. S-1 is an active anticancer agent for advanced thymic carcinoma
  26. Long-term survival following metachronous intratumoral hemorrhage in an HIV-infected patient with lung cancer
  27. Acute Adverse Effects of Radiation Therapy on HIV-positive Patients in Japan: Study of 31 Cases at Tokyo Metropolitan Komagome Hospital
  28. Choroidal metastasis in a patient with small cell lung cancer discovered during treatment with chemotherapy
  29. A case of polymyositis in a chronic hepatitis C patient treated with peg-interferon-alpha 2b and ribavirin therapy